CAM Guidance Confuses Issue Of FDA Authority, Omits Key Points, Groups Say

Dietary supplement industry trade groups say FDA's draft guidance intended to clarify the agency's regulation of complementary and alternative medicine products in fact confuses the issue further, with one group saying the draft should be withdrawn